NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDCR E-033-2004-0-AU-06 Multipotent Postnatal Stem Cells From Human Periodontal Ligament AU National Stage 2004293841 Issued
NCI E-042-1998-0-US-05 DLC-1 Gene Deleted in Cancers US CON 10/995,914 7534565 Abandoned PDF
NCI E-035-2004-2-PCT-01 Stem Cell Factor (SCF) Stimulates Neural Stem Cell Migration To Sites Of Brain And Spinal Cord Injury PCT PCT COMB PCT/US2004/039376 Expired
NIDCR E-033-2004-0-PCT-02 Multipotent Postnatal Stem Cells From Human Periodontal Ligament PCT PCT PCT/US2004/039248 Expired
NCI E-137-2002-0-US-03 METHODS FOR TREATING CANCER IN HUMANS US National Stage 10/508,978 Abandoned
NCI E-161-2004-0-US-01 Identification of proteins in a Genome US 60/628,948 Abandoned
NHLBI E-120-2003-1-HK-06 Method of Inducing Memory B Cell Development and Terminal Differentiation HK EP 06110896.8 Abandoned
NHLBI E-120-2003-1-DK-08 Method of Inducing Memory B Cell Development and Terminal Differentiation DK EP 04811794.9 Issued
NHLBI E-120-2003-1-FR-09 Method of Inducing Memory B Cell Development and Terminal Differentiation FR EP 04811794.9 Issued
NHLBI E-120-2003-1-DE-07 Method of Inducing Memory B Cell Development and Terminal Differentiation DE EP 04811794.9 Issued
NHLBI E-120-2003-1-EP-03 Method of Inducing Memory B Cell Development and Terminal Differentiation EP National Stage 04811794.9 Issued
NCI E-056-2002-0-US-03 SPECIFICITY GRAFTING OF A MURINE ANTIBODY ONTO A HUMAN FRAMEWORK US National Stage 10/515,149 7456260 Abandoned PDF
NCI E-281-2008-0-US-03 Novel Lamda Phagc Display System And The Process US National Stage 10/515,150 7410801 Abandoned PDF
NCI E-124-1996-0-US-06 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE 1 AND RELATED COMPOSITIONS AND METHODS US DIV 10/993,191 7297493 Expired PDF
NHLBI E-120-2003-1-GB-04 Method of Inducing Memory B Cell Development and Terminal Differentiation GB National Stage 0609952.7 Issued
NHLBI E-120-2003-1-PCT-02 Method of Inducing Memory B Cell Development and Terminal Differentiation PCT PCT PCT/US2004/039135 Expired
NCI E-037-2004-0-PCT-02 TARGETED CONJUGATES WITH A MODIFIED SACCHARIDE LINKER PCT PCT PCT/US2004/038781 Expired
NCI E-203-2004-0-US-01 Improved Replication-Competent Adenoviral Vectors US 60/629,722 Abandoned
NEI E-094-2003-0-US-01 Formulation Of Triamcinolone Acetonide Suspension For Intravitreal Delivery By Injection US 60/628,741 Abandoned
NCI E-190-2002-2-US-02 Identification of a Novel (BHD) Gene US National Stage 10/514,744 7485709 Abandoned PDF
NCI E-065-2002-0-US-03 ELISA Assay of Serum Soluble CD22 to Assess Tumor Burden/Relapse in Subjects with Leukemia and Lymphoma US National Stage 10/514,910 Abandoned
NIEHS E-103-2000-2-US-01 New Biological Potent Analogues Of The DMT-TIC Pharmaphore And Methods Of Use71 US 60/628,147 Abandoned
NLM E-111-2004-0-PCT-02 Methods, Articles, And Compositions For Identifying Oligonucleotides PCT PCT PCT/US2004/038092 Expired
NCI E-087-2005-0-EP-06 Custom Vectors for Treating and Preventing Pancreatic Cancer EP National Stage 04811370.8 Issued
NCI E-087-2005-0-CA-05 Custom Vectors for Treating and Preventing Pancreatic Cancer CA National Stage 2545183 Issued
NCI E-088-2005-0-CA-05 System for Treating and Preventing Breast Cancer CA National Stage 2545164 Issued
NCI E-088-2005-0-DK-15 System for Treating and Preventing Breast Cancer DK EP 04810831.0 Issued
NCI E-088-2005-0-SE-21 System for Treating and Preventing Breast Cancer SE EP 04810831.0 Issued
NCI E-088-2005-0-ES-16 System for Treating and Preventing Breast Cancer ES EP 04810831.0 Issued
NCI E-088-2005-0-GB-18 System for Treating and Preventing Breast Cancer GB EP 04810831.0 Issued
NCI E-088-2005-0-CH-13 System for Treating and Preventing Breast Cancer CH EP 04810831.0 Issued
NCI E-088-2005-0-IT-19 System for Treating and Preventing Breast Cancer IT EP 04810831.0 Issued
NCI E-088-2005-0-NL-20 System for Treating and Preventing Breast Cancer NL EP 04810831.0 Issued
NCI E-088-2005-0-EP-06 System for Treating and Preventing Breast Cancer EP National Stage 04810831.0 Issued
NCI E-088-2005-0-AT-11 System for Treating and Preventing Breast Cancer AT EP 04810831.0 Issued
NCI E-088-2005-0-BE-12 System for Treating and Preventing Breast Cancer BE EP 04810831.0 Issued
NCI E-088-2005-0-DE-14 System for Treating and Preventing Breast Cancer DE EP 04810831.0 Issued
NCI E-088-2005-0-FR-17 System for Treating and Preventing Breast Cancer FR EP 04810831.0 Issued
NCI E-087-2005-0-JP-07 Custom Vectors for Treating and Preventing Pancreatic Cancer JP National Stage 2006-540033 Issued
NCI E-088-2005-0-JP-07 System for Treating and Preventing Breast Cancer JP National Stage 2006-539904 Issued
NCI E-088-2005-0-AU-04 System for Treating and Preventing Breast Cancer AU National Stage 2004289340 Issued
NCI E-087-2005-0-AU-04 Custom Vectors for Treating and Preventing Pancreatic Cancer AU National Stage 2004289368 Issued
NICHD E-158-1998-0-US-07 VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION US DIV 10/987,428 7553490 Abandoned PDF
NCI E-087-2005-0-PCT-02 Custom Vectors for Treating and Preventing Pancreatic Cancer PCT PCT PCT/US2004/38643 Expired
NCI E-088-2005-0-PCT-02 System for Treating and Preventing Breast Cancer PCT PCT PCT/US2004/037810 Expired
NICHD E-207-1999-2-US-02 Recombinant Toxin A Proten Carrier For Polysaccride Conjugate Vaccines US CON 10/987,508 Abandoned
NCI E-167-1999-0-US-05 Utilization of FPRL1 as a Functional Receptor by Serum Amyloid A (SAA) US CON 10/987,664 Abandoned
NCI E-088-2005-0-JP-09 System for Treating and Preventing Breast Cancer JP DIV 2011-179768 Abandoned
NCI E-065-2010-0-US-01 Device And Method For Ensuring The Accuracy Of A Tracking Device In A Volume US 60/626,947 Abandoned
NCI E-017-2002-0-US-06 SCYTOVIRINS AND RELATED CONJUGATES, FUSION PROTEINS, NUCLEIC ACIDS, VECTORS, HOST CELLS, COMPOSITIONS, ANTIODIES, AND METHODS OF USING SCYTOVIRINS US National Stage 10/513,961 7491798 Abandoned PDF